Professional
Added to YB: 2025-09-24
Pitch date: 2025-07-24
DERM [neutral]
Journey Medical Corporation
+0.26%
current return
Author Info
No bio for this author
Company Info
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
Market Cap
$201.1M
Pitch Price
$7.65
Price Target
20.00 (+161%)
Dividend
N/A
EV/EBITDA
-165.92
P/E
-19.72
EV/Sales
3.39
Sector
Pharmaceuticals
Category
growth
Summers Value Partners Portfolio Holding: Journey Medical Corporation
DERM (holding update): Dermatology pharma co led by ex-Medicis team. Emrosi launched Apr 2024 for rosacea, superior to prior standard Oracea in Phase 3 trials, patent to 2039. Early sales $15M+ annualized, targeting $100M in few years. $55M 2024 rev, forecasting $1.50 EPS by 2027. Price target $20.
Read full article (1 min)